Blood plasma is big business — especially along the U.S.–Mexico border. Every day, thousands of Mexican citizens cross ...

DelveInsight's Acute on Chronic Liver Failure Market Insights report includes a comprehensive understanding of current ...

Grifols, S.A. earns a Buy rating after strong Q3 '25 results, growth forecasts, and a restored dividend. Click for this GRFS ...

Blood plasma is a necessary resource to produce life-saving medicine. Because people are the only source, donors are often ...

Spanish plasma-derived medicines company Grifols today announced the appointment of Tomás Dagá, Grifols’ board member, as ...

Listen to the full conversation as 97.9 The Hill's Aaron Keck has an in-depth conversation with Prof. Aryeh Shander about ...

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. Grifols, S.A. is one of them. Grifols, S.A. (NASDAQ:GRFS) tops our list for being one of the hot stocks to ...

Grifols, S.A. (NASDAQ:GRFS) tops our list for being one of the hot stocks to buy. It is headquartered in Barcelona and is a global healthcare company specializing in plasma-derived therapies, ...

According to DelveInsight's analysis, the acute on chronic liver failure market is anticipated to increase during the forecast period (2025-2034), owing to the launch of emerging therapies such ...

You’ve heard that you can donate plasma for money, and maybe you’ve thought of doing it. But you likely have questions. If you’re thinking of doing it, you can feel great about yourself. It’s a ...